Ultrasound Workspace (UWS 6.0) vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Tempus

AI Verdict

Tool A is a comprehensive echocardiography viewing, analysis, and reporting system that streamlines workflows and provides detailed quantitative measurements from ultrasound images. Tool B, conversely, is an AI-powered software that analyzes ECG recordings to detect signs associated with low left ventricular ejection fraction, serving as a screening tool for heart failure risk. While both contribute to cardiovascular diagnostics and touch upon LVEF, they utilize distinct input modalities and serve different primary functions within the clinical pathway.

Choose Ultrasound Workspace (UWS 6.0) if…

Choose Philips Ultrasound Workspace (UWS 6.0) if your cardiology department requires a comprehensive, scalable system for advanced echocardiography viewing, analysis, and reporting across multiple vendors. This tool is ideal for streamlining complex workflows, enhancing diagnostic confidence with AI-powered measurements, and ensuring high reproducibility in a high-volume cardiac imaging environment.

View Ultrasound Workspace (UWS 6.0) →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your clinical setting needs a rapid, non-invasive screening tool to identify patients aged 40 or older at risk of low left ventricular ejection fraction (LVEF ≤40%) using standard 12-lead ECGs. This AI software is best suited for primary care, emergency medicine, or internal medicine to quickly flag patients who may require further cardiac evaluation for heart failure.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Ultrasound Workspace (UWS 6.0) Tempus ECG-Low EF
Deployment On-premise (single-seat workstation, multi-seat server) Integrates with current ECG platforms and electronic health records (EHRs).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ultrasound Workspace (UWS 6.0)

Tool A (Ultrasound Workspace) is described as a holistic system with consistent on- and off-cart diagnostic capabilities and web-based access for remote image review, analysis, and reporting, suggesting a flexible and comprehensive user experience. In contrast, Tool B (Tempus ECG-Low EF) lacks a dedicated user interface, operating primarily as a backend processing tool integrated into existing medical systems, which limits direct user interaction.

Clinical Value

Tempus ECG-Low EF

Tool B (Tempus ECG-Low EF) offers a novel and scalable screening tool for identifying patients at risk of low left ventricular ejection fraction (LVEF) from widely available ECGs, enabling earlier intervention for heart failure. While Tool A enhances diagnostic confidence and reproducibility in echocardiography, Tool B's ability to identify at-risk patients from a common, inexpensive test for a critical condition provides a potentially broader population health impact.

Pricing & Value

Tempus ECG-Low EF

Tool B (Tempus ECG-Low EF) has a significant advantage due to its recent inclusion in the CMS 2025 Hospital Outpatient Prospective Payment System, with a defined Medicare reimbursement rate of $128.90. This provides a clear financial pathway for healthcare providers. Tool A (Ultrasound Workspace) only states 'contact for pricing' and 'flexible licensing models,' offering no public transparency or established reimbursement details.

Enterprise Readiness

Ultrasound Workspace (UWS 6.0)

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, establishing foundational readiness. However, Tool A (Ultrasound Workspace) explicitly details a 'scalable technology platform,' 'server-client network infrastructure,' and 'Integration with existing PACS and EMR systems,' indicating a more robust and proven enterprise deployment model. Tool B mentions integration into workflows but with less specific architectural detail.

Innovation

Tempus ECG-Low EF

Tool B (Tempus ECG-Low EF) demonstrates high innovation by leveraging AI to extract predictive insights for low LVEF from ubiquitous and inexpensive 12-lead ECGs, potentially transforming early detection of heart failure at scale. While Tool A offers innovative AI-powered automated measurements for echocardiography, Tool B's application of AI to unlock new predictive power from existing, simple data for a critical condition is arguably more disruptive.

Support & Docs

Ultrasound Workspace (UWS 6.0)

Tool A (Philips Ultrasound Workspace) benefits from Philips' established infrastructure, offering a 'Professional resource center' with instructions for use, technical descriptions, and regulatory documents, alongside a 'Customer Services Portal' for managing service tickets. Tool B (Tempus ECG-Low EF) provides general contact information for support but lacks similarly detailed and structured public documentation or a dedicated support portal for its specific product.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Ultrasound Workspace (UWS 6.0) Tempus ECG-Low EF
Product Name Ultrasound Workspace (UWS 6.0) Tempus ECG-Low EF
Company Philips Ultrasound Tempus AI
Primary Function Holistic, scalable, AI-powered cardiovascular viewing, analysis, and reporting system designed to streamline echocardiography workflows, enhance diagnostic confidence, and improve reproducibility through vendor-neutral data analysis and flexible deployment. FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation.
Key AI Functionality AI-powered automated measurements (e.g., Auto Measure, AutoStrain LV, 3D Auto RV, 3D Auto MV, 3D Auto TV, 3D Auto CFQ); Vendor-neutral and multi-vendor data analysis. AI-powered algorithm for ECG analysis; Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%); Analyzes resting, non-ambulatory 12-lead ECG recordings; Provides a binary output (Low LVEF Detected / Not Detected).
Specialties Cardiology, Critical Care, Radiology Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Ultrasound Workspace (UWS 6.0) and Tempus ECG-Low EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Philips Ultrasound Workspace (UWS 6.0) is designed to streamline echocardiography workflows, enhance diagnostic confidence, and improve reproducibility through AI-powered cardiovascular viewing, analysis, and reporting. Tempus ECG-Low EF analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure.
Philips Ultrasound Workspace (UWS 6.0) analyzes echocardiography images and data, providing automated measurements and comprehensive cardiovascular software solutions. Tempus ECG-Low EF analyzes resting, non-ambulatory 12-lead ECG recordings to identify patterns associated with low LVEF.
Philips Ultrasound Workspace (UWS 6.0) offers flexible deployment as an on-premise workstation or server-client network, with web-based access and integration with existing PACS and EMR systems. Tempus ECG-Low EF is deployed as software integrated into healthcare facility workflows, intended for use in clinical diagnostic settings.
Philips Ultrasound Workspace (UWS 6.0) provides AI-powered automated measurements (e.g., Auto Measure, AutoStrain LV, 3D Auto RV) and comprehensive review, image analysis, reporting, and image management capabilities. Tempus ECG-Low EF delivers a binary output ('Low LVEF Detected' / 'Not Detected') to aid clinicians in further evaluation of patients at risk of heart failure.
Yes, Philips Ultrasound Workspace (UWS 6.0) explicitly offers vendor-neutral and multi-vendor data analysis for standardization in echocardiography. Tempus ECG-Low EF does not specify vendor-neutral analysis; its function is focused on analyzing 12-lead ECG recordings.
Philips Ultrasound Workspace (UWS 6.0) is designed for Cardiology, Critical Care, and Radiology specialties. Tempus ECG-Low EF is intended for Cardiology, Emergency Medicine, and Internal Medicine.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.